Chiara Carcieri

608 total citations
20 papers, 443 citations indexed

About

Chiara Carcieri is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Chiara Carcieri has authored 20 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Chiara Carcieri's work include HIV/AIDS drug development and treatment (8 papers), Hepatitis C virus research (6 papers) and Antifungal resistance and susceptibility (4 papers). Chiara Carcieri is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Hepatitis C virus research (6 papers) and Antifungal resistance and susceptibility (4 papers). Chiara Carcieri collaborates with scholars based in Italy, United States and Switzerland. Chiara Carcieri's co-authors include Antonio D’Avolio, Giovanni Di Perri, Amedeo De Nicolò, F. Favata, Jessica Cusato, Marco Simiele, Alessandra Ariaudo, Lucio Boglione, Chiara Simona Cardellino and Sarah Allegra and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, British Journal of Clinical Pharmacology and Journal of Pharmacy and Pharmacology.

In The Last Decade

Chiara Carcieri

20 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Carcieri Italy 11 210 131 118 103 68 20 443
Alessandra Ariaudo Italy 9 156 0.7× 79 0.6× 104 0.9× 107 1.0× 86 1.3× 18 412
Anura L. Jayewardene United States 14 353 1.7× 99 0.8× 72 0.6× 74 0.7× 114 1.7× 23 628
Puran Singhal India 15 100 0.5× 53 0.4× 33 0.3× 114 1.1× 91 1.3× 34 464
Manish Yadav India 12 81 0.4× 50 0.4× 29 0.2× 124 1.2× 89 1.3× 23 430
P. Hsyu United States 8 160 0.8× 110 0.8× 29 0.2× 27 0.3× 88 1.3× 15 479
Andrew Walubo South Africa 13 134 0.6× 56 0.4× 21 0.2× 91 0.9× 65 1.0× 29 493
Araz Raoof Belgium 11 230 1.1× 85 0.6× 22 0.2× 48 0.5× 142 2.1× 22 608
Patricia Lizak United States 15 296 1.4× 118 0.9× 17 0.1× 125 1.2× 69 1.0× 23 637
Rita de Cássia Elias Estrela Brazil 10 159 0.8× 41 0.3× 19 0.2× 41 0.4× 42 0.6× 20 283
G Tossini Italy 7 141 0.7× 109 0.8× 75 0.6× 24 0.2× 56 0.8× 11 320

Countries citing papers authored by Chiara Carcieri

Since Specialization
Citations

This map shows the geographic impact of Chiara Carcieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Carcieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Carcieri more than expected).

Fields of papers citing papers by Chiara Carcieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Carcieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Carcieri. The network helps show where Chiara Carcieri may publish in the future.

Co-authorship network of co-authors of Chiara Carcieri

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Carcieri. A scholar is included among the top collaborators of Chiara Carcieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Carcieri. Chiara Carcieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cusato, Jessica, Amedeo De Nicolò, Lucio Boglione, et al.. (2018). Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. Infection Genetics and Evolution. 60. 42–47. 4 indexed citations
2.
Cusato, Jessica, Lucio Boglione, Amedeo De Nicolò, et al.. (2018). Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. Cancer Chemotherapy and Pharmacology. 81(3). 615–620. 8 indexed citations
3.
Cusato, Jessica, Amedeo De Nicolò, Lucio Boglione, et al.. (2018). Vitamin D Pathway Gene Polymorphisms Affecting Daclatasvir Plasma Concentration at 2 Weeks and 1 Month of Therapy. Pharmacogenomics. 19(8). 701–707. 1 indexed citations
4.
Cusato, Jessica, Amedeo De Nicolò, Lucio Boglione, et al.. (2018). Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. Journal of Antimicrobial Chemotherapy. 73(6). 1659–1664. 8 indexed citations
5.
Allegra, Sarah, Silvia De Francia, Elisa Pirro, et al.. (2018). Pharmacogenetic of Voriconazole Antifungal Agent in Pediatric Patients. Pharmacogenomics. 19(11). 913–925. 26 indexed citations
6.
Cusato, Jessica, Amedeo De Nicolò, Lucio Boglione, et al.. (2017). Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. Journal of Antimicrobial Chemotherapy. 72(10). 2846–2849. 8 indexed citations
7.
Calcagno, Andrea, Nicole Pagani, Alessandra Ariaudo, et al.. (2017). Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure. Journal of Antimicrobial Chemotherapy. 72(6). 1741–1744. 8 indexed citations
8.
Simiele, Marco, Alessandra Ariaudo, Amedeo De Nicolò, et al.. (2017). UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 138. 223–230. 43 indexed citations
9.
Boglione, Lucio, Amedeo De Nicolò, Simone Mornese Pinna, et al.. (2017). Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. Digestive and Liver Disease. 49(6). 705–708. 2 indexed citations
10.
Cusato, Jessica, Lucio Boglione, Amedeo De Nicolò, et al.. (2017). Association of Vitamin D Pathway SNPs and Clinical Response to Interferon In a Cohort of HBeAg-Negative Patients. Pharmacogenomics. 18(7). 651–661. 9 indexed citations
11.
Carcieri, Chiara, Marco Simiele, Amedeo De Nicolò, et al.. (2017). Cannabinoids concentration variability in cannabis olive oil galenic preparations. Journal of Pharmacy and Pharmacology. 70(1). 143–149. 54 indexed citations
12.
Allegra, Sarah, Silvia De Francia, F. Favata, et al.. (2017). Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. British Journal of Clinical Pharmacology. 84(1). 197–203. 44 indexed citations
13.
Allegra, Sarah, Silvia De Francia, F. Favata, et al.. (2017). Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. Clinical and Experimental Pharmacology and Physiology. 44(11). 1083–1088. 18 indexed citations
14.
Allegra, Sarah, Silvia De Francia, F. Favata, et al.. (2017). Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. Biomedicines. 5(4). 66–66. 15 indexed citations
15.
Cusato, Jessica, Lucio Boglione, Amedeo De Nicolò, et al.. (2017). Pharmacogenetic Analysis of Hepatitis C Virus Related Mixed Cryoglobulinemia. Pharmacogenomics. 18(7). 607–611. 5 indexed citations
16.
Cusato, Jessica, Lucio Boglione, Amedeo De Nicolò, et al.. (2016). Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia. Pharmacogenetics and Genomics. 26(6). 307–310. 10 indexed citations
17.
Boglione, Lucio, Simone Mornese Pinna, Chiara Simona Cardellino, et al.. (2016). Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. Infection. 45(1). 103–106. 10 indexed citations
18.
Ariaudo, Alessandra, F. Favata, Amedeo De Nicolò, et al.. (2016). A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 125. 369–375. 111 indexed citations
19.
Simiele, Marco, Chiara Carcieri, Amedeo De Nicolò, et al.. (2015). A LC–MS method to quantify tenofovir urinary concentrations in treated patients. Journal of Pharmaceutical and Biomedical Analysis. 114. 8–11. 23 indexed citations
20.
D’Avolio, Antonio, Chiara Carcieri, Jessica Cusato, et al.. (2014). Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. Journal of Antimicrobial Chemotherapy. 69(11). 3061–3066. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026